La Jolla Labs was founded to make modern RNA biology and advanced computational techniques directly useful to patients whose ...

Current methods for the determination of RNA quantity/quality/integrity are labor-intensive, costly, and often cannot deliver adequate information or analyze high numbers of samples. New developments ...

A new research paper featured as the cover of Volume 17, Issue 12 of Aging-US was published on December 22, 2025, titled “A ...

In advanced therapy development, blood samples are essential to gain molecular insights. RNA and biomarker profiles are highly sensitive to preanalytical variables—such as collection, transport, ...

Researchers have developed a groundbreaking microscopy method that enables detailed three-dimensional (3D) RNA analysis at cellular resolution in whole intact mouse brains. The new method, called ...

Key opportunities lie in next-generation sequencing methods, with hospitals as major end-users and North America as a ...

STORM Therapeutics has entered a new collaboration with US‑based AlidaBio to accelerate the development of cancer therapies that target RNA modifications.

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida ...

Real-time reverse transcription PCR analysis of RNA expression in normal and diseased states is a fundamental technique used in research workflows. Immortalized and primary cells are often used to ...

Early detection is critical when it comes to curing diseases like cancer, but not everyone has easy access to screening tools. For problems in the genitourinary (GU) tract (which includes the kidneys, ...